Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients
NCT07701512
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Intracranial Hemorrhage
Interventions
DRUG:
Febuxostat 40 mg
DRUG:
Standard medical treatment
Sponsor
Tanta University